Dr Michael Dally is an experienced radiation oncologist at Icon Cancer Centre Richmond, Freemasons, Mulgrave and Hobart, with a sub-speciality interest in neuro-oncology and stereotactic radiosurgery. He was the first in Victoria to develop stereotactic irradiation at the Alfred Hospital, affiliated with Monash University in 1996.
In addition to an interest in clinical trials and quality of life, he has taught stereotactic radiosurgery for benign, malignant and functional CNS conditions through the BrainlabAG teaching academy in Australia, Asia and Europe. He has been an invited guest speaker in China, Korea, Malaysia and India as well as for the Neurosurgery Society of Australia. Dr Dally has also been part of the neurosurgical trainee (SET) faculty on a number of occasions.
He is the principal investigator for SHRINC – a phase II study of Stereotactic Hypofractionated Stereotactic Radiosurgery Including Neurological and Cognitive assessment and is currently investigating radiosurgery for Parkinson’s disease and essential tremor.
He has a passion for assisting patients with making sometimes difficult decisions often where information is outdated, outmoded or just overwhelming. He welcomes questions and as a starting point suggests:
- What is the natural history or what will happen if I do nothing?
- How does the proposed treatment compare with other strategies eg. Surgery, in terms of outcome and risk?
- What are the limitations of the proposed treatment, that is, what can’t be achieved?
- Is this equipment the best available? Has the treatment process been subject to independent quality review and found to meet international standards of excellence?
- How many similar patients has your doctor treated and how do the results compare with worldwide benchmarks?
- Has your doctor published in this area?
- Ask if there are other important questions that have not been asked.